Two other mAbs targeting MMP-9, AB0041 and AB0046, were found to inhibit tumor growth and metastasis in a surgical orthotopic xenograft model of colorectal carcinoma [81] while reducing the musculoskeletal syndrome usually caused as a side effect of non-selective MMP inhibitors [81]. This evidence concerns the gene MMP9 and neoplasm.